BDX vs CRL Stock Comparison
BDX currently leads CRL in this stock comparison, with AIQ scores of 59 vs 51. The clearest difference is value, while CRL has the stronger momentum profile.
What is the main difference between BDX and CRL?
BDX leads the current stock comparison as Becton, Dickinson and Company, with the clearest separation coming from value and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
Becton, Dickinson and Company vs Charles River Laboratories International, Inc.
BDX leads
BDX leads by 8 AIQ points, primarily on Value and Quality, and the lead has widened from 4 points over 30 sessions.
Stable: 5 of 6 evidence groups support BDX, its lead is widening, and its signal state is cleanly positive.
Becton, Dickinson and Company
Charles River Laboratories International, Inc.
The Algovestiq AIQ Score currently favors BDX over CRL, 59 versus 51 as of Oct 31, 2026. BDX's advantage is driven primarily by stronger value and quality, while CRL holds the stronger momentum profile. BDX also shows the weaker technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor BDX today, and the comparison is rated Stable on stability. BDX lead: Strengthening — the AIQ differential moved from 4 to 8 points over 30 sessions.
Compare Becton, Dickinson and Company and Charles River Laboratories International, Inc. across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Total return with distributions reinvested, from daily closes.
Total return comparison
Growth of $10,000, distributions reinvested
Split-adjusted closes; each distribution is reinvested at the close on its ex-dividend date. Taxes and trading costs are not modeled.
Compare BDX and CRL against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Value63 vs 42BDX +21
- Quality44 vs 29BDX +15
- Momentum80 vs 95CRL +15
- Risk Resilience49 vs 41BDX +8
5 of 6 evidence groups favor BDX. BDX’s edge is concentrated in value and quality; CRL keeps a meaningful momentum edge.
What changed since the last close
Latest scored session 2026-10-28, compared against the prior scored session 2026-10-27.
Largest factor move: Momentum -1
No signal started or stopped since the prior session; its 4 active signals are unchanged.
No factor moved materially.
No signal started or stopped since the prior session; its 9 active signals are unchanged.
BDX's lead narrowed by 1 AIQ point in the latest session.
Deeper signal detail for each name lives on its own signals page — BDX and CRL both carry a full feed there.
The central trade-off
BDX (Becton, Dickinson and Company): the stronger current systematic profile, led by value and quality.
CRL (Charles River Laboratories International, Inc.): the counter-case, on momentum, technicals — but at materially higher volatility, 50.6% against 21.9%.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
BDXBDX on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
BDXBDX on combined revenue and EPS growth.
Value
BDXBDX on the peer-relative Value factor, by 21 points.
Momentum
CRLCRL on the Momentum factor, by 15 points.
Lower downside
BDXBDX on Risk Resilience, by 8 points.
Analyst upside
BDXBDX on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | BDX | CRL | Note |
|---|---|---|---|
| Implied upside to target | -4.4% | -21.4% | BDX has more room |
| Target dispersion | +23.8% | +58.4% | Lower is tighter analyst agreement |
| Consensus | Hold | Buy | Context, not a primary driver |
| Analysts covering | 6 | 14 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor BDX. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | BDX | 59 vs 51 |
| Fundamentals | BDXon balance | EPS growth 223.4% vs 90%; TTM ROE 3.8% vs -7.7%; gross margin 46.1% vs 32.2%; operating margin 9.8% vs 12.3% — BDX takes 3 of 4 decided legs, not all of them |
| Valuation | BDX | Value 63 vs 42 |
| Technicals | CRL | Price vs 50-day 6.3% vs 20.3%; vs 200-day 15% vs 63.5% |
| Risk Resilience | BDX | Risk Resilience 49 vs 41 |
| Analyst expectations | BDX | Target upside -4.4% vs -21.4% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of BDX and CRL and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is moderate at 8 points.
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's advantage has been widening. (supports the conclusion holding)
- The lead has been steady session to session. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on BDX.
How the comparison changed
120 daily snapshots · Jun 29 – Oct 28BDX lead: Strengthening — the AIQ differential moved from 4 to 8 points over 30 sessions.
- Today
- BDX +8
- 59 vs 51
- 7 sessions ago
- BDX +10
- 60 vs 50
- 30 sessions ago
- BDX +4
- 50 vs 46
- 90 sessions ago
- BDX +11
- 59 vs 48
The lead has not changed hands in this window.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
4 bullish / 0 bearish
No signal that the other name lacks.
6 bullish / 2 bearish / 1 neutral, conflicted
Only CRL
- ATR Expansion - Breakout Mode — neutral, volatility, short horizon (3.62%)
- BB Upper Band Breach — bearish, volatility, short horizon
- Keltner Channel Breakout — bullish, volatility, short horizon
- RSI Overbought — bearish, momentum, short horizon
- 52-Week High Proximity — bullish, risk, long horizon (0.0%)
Both carry 4 more signals that do not separate them: Golden Cross Active, EMA Ribbon Expansion Bullish, Uptrend Structure Active, MACD Bullish Crossover.
CRL is conflicted, so the timing case there is weaker than the score alone suggests.
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Price and the AIQ Score both moved down over the latest session (price -0.23%, AIQ -1 points).
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -4.44%, AIQ 0 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CRL closes the Value gap — currently 21 points behind, the largest single contributor to BDX's edge.
- 2CRL's BB Upper Band Breach resolves — a bearish volatility rule currently active against it.
- 3BDX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
BDX leads on balance| Metric | BDX | CRL |
|---|---|---|
| Revenue growth (YoY) | 5.7% | 0.8% |
| EPS growth (YoY) | 223.4% | 90% |
| Gross margin | 46.1% | 32.2% |
| Operating margin | 9.8% | 12.3% |
| Return on equity (TTM) | 3.8% | -7.7% |
| Debt to equity | 0.69 | 1.07 |
Performance
CRL leads 6 of 6 windows| Metric | BDX | CRL |
|---|---|---|
| 1 week (5 sessions) | 0.4% | 8.4% |
| 1 month (20 sessions) | 9% | 26.8% |
| 3 months (63 sessions) | 18% | 59.4% |
| 6 months (126 sessions) | 30.7% | 109.7% |
| Year to date | 0.6% | 73.1% |
| 1 year (252 sessions) | 5% | 89.8% |
Technicals
CRL has the stronger structure| Metric | BDX | CRL |
|---|---|---|
| RSI (14) | 69.2 | 86.3 |
| ADX (14) | 35 | 45.6 |
| Price vs 50-day | 6.3% | 20.3% |
| Price vs 200-day | 15% | 63.5% |
| Volatility (1M, annualized) | 21.9% | 50.6% |
Risk
BDX is the more resilient| Metric | BDX | CRL |
|---|---|---|
| Beta | 0.33 | 1.29 |
| Sharpe ratio | 0.22 | 1.65 |
| Sortino ratio | 0.27 | 2.59 |
| Max drawdown | -33% | -33.9% |
| Current drawdown | -7.1% | 0% |
| Annualized volatility | 31% | 46% |
| Value at risk (95%) | -2.3% | -3.7% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, BDX or CRL?
On the Algovestiq AIQ Score, BDX is the stronger of the two as of Oct 31, 2026, scoring 59 against CRL's 51. The edge comes from value and quality. CRL is not without a case — it holds the better momentum profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is BDX or CRL the better buy right now?
BDX carries the stronger systematic profile as of Oct 31, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor BDX over CRL?
The composite weights Quality, Value, Momentum and Risk Resilience. BDX leads Value by 21 points; BDX leads Quality by 15 points; CRL leads Momentum by 15 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, BDX or CRL?
Analyst price targets imply -4.4% upside for BDX and -21.4% for CRL, so the Street currently favors BDX. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, BDX or CRL?
BDX is the better-valued of the two on the peer-relative Value factor. BDX on the peer-relative Value factor, by 21 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, BDX or CRL?
BDX on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, BDX or CRL?
CRL on the Momentum factor, by 15 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, BDX or CRL?
BDX is the more resilient of the two, so the other name carries the higher downside risk. BDX on Risk Resilience, by 8 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is BDX more profitable than CRL?
The profitability evidence is mixed: gross margin 46.1% vs 32.2%; operating margin 9.8% vs 12.3%; ttm roe 3.8% vs -7.7%. BDX leads on two measures and CRL on one measure, and there is no single profitability composite that resolves the split — which of the two reads as "more profitable" depends on whether you weight pricing power or operating leverage.
Is BDX's lead over CRL getting stronger or weaker?
BDX lead: Strengthening — the AIQ differential moved from 4 to 8 points over 30 sessions. This is measured from 120 daily comparison snapshots between 2026-06-29 and 2026-10-28. The lead has not changed hands in that window.
What would change the BDX vs CRL verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CRL closes the Value gap — currently 21 points behind, the largest single contributor to BDX's edge; CRL's BB Upper Band Breach resolves — a bearish volatility rule currently active against it; BDX's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about BDX and CRL?
BDX: 4 bullish / 0 bearish. CRL: 6 bullish / 2 bearish / 1 neutral, conflicted. A conflicted state means bullish and bearish rules are active on the same name at once — the technical evidence is not pointing one way, and a decision taken on it carries more timing risk. The most decision-relevant rule on BDX is Golden Cross Active (bullish, long horizon). On CRL it is Golden Cross Active (bullish, long horizon).
Compare BDX and CRL with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.